About Augmented Intelligence in Healthcare
Augmented intelligence offers the enhanced capabilities of human decision-making in clinical and healthcare settings. The healthcare systems are augmented with computation systems tools, technologies, and methods. The augmented intelligence in healthcare is used in various applications like care coordination command center, mental health tracking, population health management, research & drug discovery, precision medicine, healthcare assistance robots, medical imaging & diagnostics, and others. It replicates the human's intelligence and provides enhanced results while eliminating the errors using technology like machine learning, deep learning, computer vision, cognitive technology, etc.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Intel Corporation (United States), Nvidia Corporation (United States), Health Catalyst (United States), Nuance Communications, Inc (United States), Google Inc. (United States), Microsoft Corporation (United States), International Business Machines Corporation (United States), Siemens Healthcare GmbH (Germany), SD Global Technologies (Malaysia), General Electric (United States), Agfa HealthCare (Belgium) and Augmented Intelligence, Inc. (Mai) (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Augmented Intelligence in Healthcare market by , Application (Care Coordination Command Center, Mental Health Tracking, Population Health Management, Research & Drug Discovery, Precision Medicine, Healthcare Assistance Robots, Medical Imaging & Diagnostics and Others) and Region.
On the basis of geography, the market of Augmented Intelligence in Healthcare has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. Hardware {Wearables, Sensors, Remote Monitoring Device, Others} will boost the Augmented Intelligence in Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Computer Vision will boost the Augmented Intelligence in Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Emerging Telehealth and AI Related Technologies for Mental Health Treatment and Drug Discovery Research
Market Growth Drivers:
Growing Demand for Augmented Technology for Increased Efficiency and Faster Diagnosis for Timely Treatment in Healthcare Industry and Need for Eliminating and Mitigating the Human Errors in Healthcare Activities which are Complex for Human to Perform
Challenges:
Lack of Augmented Intelligence Infrastructure in Rural Healthcare System Hindering the Market
Restraints:
Privacy Related Regulatory Guidelines on Augmented Intelligence in Healthcare
Opportunities:
Surging Government Projects and Spendings on the Advancement of Augmented Intelligence in Healthcare and Surging Demand for Augmented Intelligence in Healthcare from Developing Countries
Market Leaders and their expansionary development strategies
In March 2023, Medtronic and NVIDIA, the world's largest provider of medical technology, teamed up to build an AI platform for medical devices, accelerating the development of AI in healthcare systems and bringing new AI-powered solutions to patient care. The two companies have integrated NVIDIA Healthcare and Edge AI technologies into Medtronic's GI Genius intelligent endoscope module developed and manufactured by Cosmo Pharmaceuticals. GI Genius is the first FDA-approved, AI-powered colonoscopy tool that helps doctors detect polyps that can lead to colorectal cancer.
On 10th March 2021, Health Catalyst, Inc. a leading provider of data and analytics technology and services to healthcare organizations, announced the launch of the new Healthcare.AI. Created to address healthcare business opportunities and challenges across revenue, cost, and quality, the Healthcare.AI suite of augmented intelligence (AI) products, and services will significantly expand the effective use and use cases of AI in healthcare.
"Health care organizations are using artificial intelligence (AI)—which the U.S. Food and Drug Administration defines as “the science and engineering of making intelligent machines”—for a growing range of clinical, administrative, and research purposes. The regulatory framework governing these tools is complex. FDA regulates some—but not all—AI-enabled products used in health care, and the agency plays an important role in ensuring the safety and effectiveness of those products under its jurisdiction. The agency is currently considering how to adapt its review process for AI-enabled medical devices that have the ability to evolve rapidly in response to new data, sometimes in ways that are difficult to foresee."
Key Target Audience
Augmented Intelligence in Healthcare Providers, Augmented Intelligence Platform Developers, Healthcare Industry Association, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.